MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
Additive Manufacturing technology has continually advanced, allowing microstructure and property optimization. In recent years, several studies have been carried out with the aim of understanding ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Abstract: The mechanical properties of the Ti-6Al-4V alloy make it a promising material for high-temperature applications. However, uncertainties surround the long-term performance and reliability of ...
Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback